Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
72.5 USD | -.--% | -.--% | +13.28% |
Valuation
Fiscal Period: May | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 29.92 | 32.2 | 53.66 | 72.54 | 62.61 | 67.98 |
Enterprise Value (EV) 1 | 20.01 | 22.99 | 59.55 | 79.44 | 79.15 | 79.3 |
P/E ratio | 8.16 x | 11.4 x | 12.7 x | 11.5 x | 11.9 x | 81.7 x |
Yield | 1.79% | 1.94% | 1.83% | 1.54% | 1.43% | 0.66% |
Capitalization / Revenue | 0.83 x | 0.82 x | 1.16 x | 1.26 x | 0.95 x | 1.08 x |
EV / Revenue | 0.56 x | 0.58 x | 1.28 x | 1.38 x | 1.2 x | 1.27 x |
EV / EBITDA | 3.33 x | 5.16 x | 9.33 x | 8.01 x | 9.6 x | 23.5 x |
EV / FCF | 22.4 x | -19.7 x | 689 x | 393 x | 85.9 x | 8.5 x |
FCF Yield | 4.47% | -5.09% | 0.15% | 0.25% | 1.16% | 11.8% |
Price to Book | 1.36 x | 1.31 x | 1.9 x | 2.16 x | 1.66 x | 1.81 x |
Nbr of stocks (in thousands) | 894 | 894 | 894 | 894 | 894 | 894 |
Reference price 2 | 33.45 | 36.00 | 60.00 | 81.10 | 70.00 | 76.00 |
Announcement Date | 12/09/18 | 13/09/19 | 14/09/20 | 17/09/21 | 24/09/22 | 22/09/23 |
Income Statement Evolution (Annual data)
Fiscal Period: May | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 35.88 | 39.48 | 46.36 | 57.68 | 66.15 | 62.66 |
EBITDA 1 | 6.014 | 4.456 | 6.383 | 9.922 | 8.245 | 3.38 |
EBIT 1 | 5.273 | 3.584 | 5.322 | 8.557 | 6.533 | 1.103 |
Operating Margin | 14.69% | 9.08% | 11.48% | 14.83% | 9.88% | 1.76% |
Earnings before Tax (EBT) 1 | 5.286 | 3.709 | 5.489 | 8.616 | 6.577 | 1.133 |
Net income 1 | 3.662 | 2.831 | 4.231 | 6.327 | 5.261 | 0.8355 |
Net margin | 10.21% | 7.17% | 9.13% | 10.97% | 7.95% | 1.33% |
EPS 2 | 4.099 | 3.169 | 4.730 | 7.077 | 5.880 | 0.9300 |
Free Cash Flow 1 | 0.894 | -1.169 | 0.0864 | 0.202 | 0.9215 | 9.325 |
FCF margin | 2.49% | -2.96% | 0.19% | 0.35% | 1.39% | 14.88% |
FCF Conversion (EBITDA) | 14.86% | - | 1.35% | 2.04% | 11.18% | 275.89% |
FCF Conversion (Net income) | 24.41% | - | 2.04% | 3.19% | 17.52% | 1,116.07% |
Dividend per Share 2 | 0.6000 | 0.7000 | 1.100 | 1.250 | 1.000 | 0.5000 |
Announcement Date | 12/09/18 | 13/09/19 | 14/09/20 | 17/09/21 | 24/09/22 | 22/09/23 |
Balance Sheet Analysis
Fiscal Period: May | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | 5.89 | 6.9 | 16.5 | 11.3 |
Net Cash position 1 | 9.91 | 9.21 | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | 0.9225 x | 0.6953 x | 2.006 x | 3.352 x |
Free Cash Flow 1 | 0.89 | -1.17 | 0.09 | 0.2 | 0.92 | 9.33 |
ROE (net income / shareholders' equity) | 17.9% | 12.1% | 16% | 20.5% | 14.8% | 2.22% |
ROA (Net income/ Total Assets) | 13.4% | 8.2% | 8.54% | 10.4% | 6.99% | 1.11% |
Assets 1 | 27.26 | 34.51 | 49.52 | 60.91 | 75.22 | 75.55 |
Book Value Per Share 2 | 24.70 | 27.50 | 31.50 | 37.50 | 42.10 | 42.10 |
Cash Flow per Share 2 | 11.40 | 10.30 | 11.50 | 8.630 | 2.440 | 8.140 |
Capex 1 | 2.07 | 1.87 | 2.4 | 4.41 | 4.89 | 2.24 |
Capex / Sales | 5.77% | 4.73% | 5.19% | 7.64% | 7.38% | 3.58% |
Announcement Date | 12/09/18 | 13/09/19 | 14/09/20 | 17/09/21 | 24/09/22 | 22/09/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+13.28% | 64.85M | |
+19.41% | 45.51B | |
-8.62% | 38.52B | |
+38.65% | 38.13B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |
- Stock Market
- Equities
- BIOQ Stock
- Financials Bioqual, Inc.